UAB Research Foundation (doing business as UABRF), a subsidiary of The University of Alabama System, is a company headquartered in Birmingham, AL. The firm engages in identify, assess, and market commercially viable technology developed at The University of Alabama at Birmingham.

Precigen, Inc. is a biotechnology company, which engages in the research and development of synthetic biology technologies. It operates through the following segments: Biopharmaceuticals, Exemplar, and Trans Ova. The Biopharmaceuticals segment is involved in advancing the next generation of gene and cell therapies using precision technology to target urgent and intractable diseases in immuno-oncology, autoimmune disorders, and infectious diseases. It also engages in pioneering a proprietary class of microbe-based biopharmaceuticals that enable expression and local delivery of disease-modifying therapeutics. The Exemplar segment is focused on developing research models and services for healthcare research applications. The Trans Ova segment provides bovine reproductive technologies. The company was founded by Thomas David Reed in 1998 and is headquartered in Germantown, MD.

CJ CheilJedang is a core subsidiary in charge of the food and bioengineering business Unit of the CJ Group. It has led the development of the Korean food industry for the past 60 years, and contributed to the development of the bioengineering industry as the nation’s top food originated company. After being launched in 1953 as a food ingredient company, continuously extended its business to processed foods. In 2007, CJ CheilJedang divided out as a subsidiary company to concentrate on the food and bioengineering business.

The Institute Pasteur is a private, non-profit foundation. Its mission is to help prevent and treat diseases, mainly those of infectious origin, through research, teaching, and public health initiatives.The Institut Pasteur is a research center of international renown ideally located in the very heart of Paris. Each year the institute hosts a multitude of scientific and medical conferences and meetings as well as events on a variety of themes.

Tianjin International Biomedical Joint Research Institute Co., Ltd., established on 2010-05-18, Business scope includes scientific and technological research and development and related consulting;Biotechnology R&D and Application;R&D and pilot test of pharmaceutical products,analysis test,Technical Services,information service;Financing Consulting;Business Consulting;House to rent;financial services;Tax agency service;Conference Services;Technology intermediary service;Daily necessities,Wholesale and retail of experimental instruments;laboratory equipment(Does not contain medical devices)research and development,Sales;laboratory materials(Does not contain food,medicine,Hazardous Chemicals and Precursors)promotion of;Wholesale and retail of prepackaged food;Entrusted to provide business services for enterprises.(Items subject to approval by law,Business activities can only be carried out after approval by relevant departments)

Beth Israel Deaconess Medical Center (BIDMC) in Boston, Massachusetts is a teaching hospital of Harvard Medical School. It was formed out of the 1996 merger of Beth Israel Hospital (founded in 1916) and New England Deaconess Hospital (founded in 1896). Among independent teaching hospitals, Beth Israel Deaconess Medical Center consistently ranks in the top three recipients of biomedical research funding from the National Institutes of Health. Research funding totals nearly $200 million annually. BIDMC researchers run more than 850 active sponsored projects and 200 clinical trials. The Harvard-Thorndike General Clinical Research Center, the oldest clinical research laboratory in the United States, has been located on this site since 1973.

Operates as an non-classified establishment

Provincial Health Services Authority (PHSA) is a publicly funded health service provider in the province of British Columbia. Other health authorities in the province have a regional jurisdiction. PHSA is unique in Canada as the only health authority having a province-wide mandate for specialized health services. Services are provided either directly through PHSA agencies or through funding or collaboration with regional health authorities.

Shanghai Jingnuo Biotechnology Co., Ltd., established on 2014-11-28, Business scope includes research of biopharmaceutical products,to develop,And provide technical development in related fields,technical consulting,Technical Services,technology transfer,Laboratory reagents and consumables(Removal of hazardous chemicals,Monitor Chemicals,civilian firecrackers,precursor chemicals)research and development,Development of laboratory instruments,Sales,Medical device research and development,Sales,Engaged in the import and export of goods and technology. [Items subject to approval by law,Business activities can only be carried out after approval by relevant departments]

KPC is a pharmaceutical company that engages in the manufacture of pharmaceuticals. Tablets, fluids, ointments, and injectables are among their offerings. Its goal is to improve people's lives by enabling them to achieve more, feel better, and live longer. They have technological machinery, skilled and motivated individuals, and management systems that can handle both quantity and quality of work. They are looking for new ways to improve their performance, raise their integrity to a level of excellence, implement their initiatives, and achieve their goals.

Imperial Innovations is a technology commercialization and venture capital investor that focuses on technology. Imperial Innovations no longer invests in startups and now functions as the technology-transfer office of Imperial College. Imperial Innovations is focused on commercialising leading UK academic research sourced from the 'golden triangle' formed between Cambridge, Oxford and London. We are a technology commercialisation company that combines the activities of technology transfer, intellectual property protection and licensing, company incubation and investment. Innovations is focused on commercialising the most promising UK academic research across a broad range of technology sectors, and has developed particular expertise in: therapeutics, medtech, engineering and materials and information communication technology.

Hunan Xinhexin Biopharmaceutical Co., Ltd., established on 2013-03-22, Business scope includes research on biomedical products,Technical consulting and technology transfer;Fine Chemicals(Free of Hazardous Chemicals),Production, sales and import and export of biological raw materials;Except for the goods and technologies that the state restricts the company to operate or prohibits the import and export of.

E. Merck KG operates as a holding company with interest in pharmaceutical preparations. It acts as a general partner that holds the majority of shares of the public company Merck KGaA. Merck KG is the parent company of all Merck companies yet it does not have any operating businesses itself. It makes the entrepreneurial policy decisions for the Merck Group. The company is headquartered in Darmstadt, Germany.

Janssen Pharmaceutica is a pharmaceutical company headquartered in Beerse, Belgium and owned by Johnson & Johnson. It was founded in 1953 by Paul Janssen. In 1961, Janssen Pharmaceutica was purchased by New Jersey-based American corporation Johnson & Johnson, and became part of Johnson & Johnson Pharmaceutical Research and Development (J&J PRD), now renamed to Janssen Research and Development (JRD), which conducts research and development activities related to a wide range of human medical disorders, including mental illness, neurological disorders, anaesthesia and analgesia, gastrointestinal disorders, fungal infection, HIV/AIDS, allergies and cancer. Janssen and Ortho-McNeil Pharmaceutical have been placed in the Ortho-McNeil-Janssen group within Johnson & Johnson Company.

Mianyang Diao Pharmaceutical Co., Ltd., established on 2014-04-21, Business scope includes raw materials,Production of traditional Chinese medicine extracts and food additives,Sales;Planting of Chinese herbal medicines,buy,processing,Sales;Comprehensive Development of Agricultural Industry;Manage the export business of the products produced by the company.(Except for export commodities that are jointly operated by national organizations)(Items subject to approval by law,Business activities can only be carried out after approval by relevant departments)

Bio-Botanica, Inc. manufactures botanical extracts. Its extracts include alfalfa, comfrey, guarana, plantain, blam mint, hawthorn, chickweed, ginseng, parsley, goldenseal, yohimbe, yucca, and horehound. The firm serves nutraceutical, natural food, beverage and cosmetic industries. The company was founded by Frank S. D'Amelio Sr. in 1972 and is headquartered in Hauppauge, NY.

Grünenthal GmbH engages in the research and development of pharmaceutical products. It specializes in pain, gout, and inflammation. The company was founded by Hermann Wirtz in 1946 and is headquartered in Aachen, Germany.

Guangzhou Institutes of Biomedicine and Health (GIBH)，(simplified Chinese: 中国科学院广州生物医药与健康研究院; traditional Chinese: 中國科學院廣州生物醫藥與健康研究院; pinyin: Zhōngguó Kēxué yuan guangzhou sheng wu yi yao yu jian kang yan jiu yuan) affiliated with the Chinese Academy of Sciences, is a government-sponsored scientific research institution with independent legal jurisdiction. GIBH was established by the Chinese Academy of Sciences, Guangdong Provincial Government and Guangzhou Municipal Government. The managerial mechanism of GIBH is the responsibility of Director-General, under the authority of the board of trustees.